Cerretti et al., “Isolation of cDNAs that encode ligands to the receptor tyrosine kinases HEK and ELK: emergence of a family of proteins that are Ligands for the EPH Related Kinases (LERKS),” Abstract for American Assoc. for Cancer Research conference on Growth Factors, Development, and Cancer, Interlaken, Switzerland, Mar. 5-11, 1994. |
Lyman et al., “Identification of a ligand for the ELK tyrosine kinase receptor,” Lymphokine Cytokine Res vol. 12, No. 5, Abstract No. 92, Oct., 1993. |
Beckmann et al., “Molecular characterization of a family of ligands for EPH-related tyrosine kinases,” Abstract for Keystone Symposium on Inflammation, Growth Regulatory Molecules, and Atherosclerosis, Keystone, CO, Jan. 16-23, 1994. |
Beal, M. F., “Role of excitotoxicity in human neurological disease,” Curr Opin Neurobiol 2:657-662, 1992. |
Choi, D. K., “Excitotoxic cell death,” J Neurobiol 23:1261-1276, 1992. |
Massieu et al., “A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy,” Neuroscience 55:883-892, 1993. |
Albin and Greenmyre, “Alternative excitotoxic hypothesis,” Neurology 42:733-738, 1992. |
Letwin et al., “Novel protein-tyrosine kinase cDNAs related to FPS/FES and EPH cloned using anti-phosphotyrosine antibody,” Oncogene 3:621-627, 1988. |
Lhotak et al., “Characterization of ELK, a brain-specific receptor tyrosine kinase,” Mol Cell Biol 11:2496-2502, 1991. |
Boyd et al., “Isolation and characterization of a novel receptor-type protein tyrosine kinase (HEK) from a human pre-B cell line,” J Biol Chem 267:3262-3267, 1992. |
Wicks et al., “Molecular cloning of HEK, the gene encoding a receptor tyrosine kinase expressed by human lymphoid tumor cell line,” Proc Natl Acad Sci USA 89:1611-1615, 1992. |
Sajjadi et al., “Identification of a new EPH-related receptor tyrosine kinase gene from mouse and chicken that is developmentally regulated and encodes at least two forms of the receptor,” New Biol 3:769-788, 1991. |
Chan and Watt, “EEK and ERK, new members of the EPH subclass of receptor protein-tyrosine kinases,” Oncogene 6:1057-1061, 1991. |
Lindberg et al., “cDNA cloning and characterization of ECK, an epithelial cell receptor protein-tyrosine kinase in the EPH/ELK family of protein kinases,” Mol Cell Biol 10:6316-6324, 1990. |
Pasquale, “Identification of chicken embryo kinase 5, a developmentally regulated receptor-type tyrosine kinase of the EPH family,” Cell Regulation 2:523-534, 1991. |
Hirai et al., “A novel putative tyrosine kinase receptor encoded by the EPH gene,” Science 238:1717-1720, 1987. |
Holzman et al., “A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein,” Mol Cell Biol 10:5830-5838, 1990. |
Ashkenazi et al., “Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin,” Proc Natl Acad Sci USA 88:10535-10539, 1991. |
Byrn et al., “Biological properties of a CD4 immunoadhesin,” Nature 344:667-670, 1990. |
Petrukhin et al., “A microsatellite genetic linkage map of human chromosome 13,” Genomics 15:76-85, 1993. |
Warburton et al., “Regional localization of 32 NotI-HindIII fragments from a human chromosome 13 library by a somatic cell hybrid panel and in situ hybridization,” Genomics 16:355-360, 1993. |
Brown et al., “Preliminary definition of a “critical region” of chromosome 13 in q32: report of 14 cases with 13q deletions and review of the literature,” Am J Med Gen 45:52-59, 1993. |
Bartley et al., “B61 is a ligand for the ECK receptor protein-tyrosine kinase,” Nature 368:558-560, 1994. |
Sakano et al., “Characterization of a ligand for receptor protein-tyrosine kinase HTK expressed in immature hematopoietic cells,” Oncogene 13:813-822, 1996. |
Bergemann et al., “ELF-2, a new member of the eph ligand family, is segmentally expressed in mouse embryos in the region of the hindbrain and newly forming somites,” Mol Cell Biol 15(9):4921-4929, Sep. 1995. |
Böhme et al., “Cell-cell adhesion mediated by binding of membrane-anchored ligand LERK-2 to the EPH-related receptor human embryonal kinase 2 promotes tyrosine kinase activity,” J Biol Chem 271(40):24747-24752, Oct. 4, 1996. |
Cerretti et al., “Ligands for the EPH-related kinases (LERKS) are developmentally regulated in the brain and are excito-protective for hippocampal neurons,” J Cell Biochem Suppl. 21B, Abstract No. D3-100, Apr. 1995. |
Böhme et al., “PCR mediated detection of a new human receptor-tyrosine-kinase HEK 2,” Oncogene 8:2857-2862, 1993. |
Schlom, “Monoclonal antibodies: they're more and less than you think,” In Molecular Foundations of Oncology, Samuel Broder, ed., Williams & Wilkins, Baltimore, MD, pp. 95-134, 1991. |
Bennett et al., “Molecular cloning of a ligand for the EPH-related receptor protein-tyrosine kinase htk,” Proc Natl Acad Sci USA 92:1866-1870, Mar. 1995. |
Cerretti et al., “Isolation of LERK-5: a ligand of the EPH-related receptor tyrosine kinases,” Mol Immunol 32(16):1197-1205, 1995. |
Bennett et al., “Molecular cloning of a ligand for the EPH-related receptor protein tyrosine kinase—HTK,” Blood 84(10), Suppl. 1, p. 427a, Abstract No. 1693, Nov. 15, 1994. |